Pharmatizing AI

Digital

In this off-the-stage interview from Frontiers Health 2025 discover how 'pharmatized' AI delivers smarter, faster, and more reliable innovation.

Oncology

Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.